pioneer trials semaglutide Efficacy and safety of oral vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: 12, a double-blind, Phase IIIa, randomised trial | Diabetologia Overview of the global PIONEER

LPS produced by intestinal flora can stimulate NF-B to recruit inflammatory factors and increase the level of inflammation in the body

Head-to-head clinical data from the SURMOUNT-5 trial shows tirzepatide (Mounjaro) achieves greater weight loss

This gradual dose escalation is designed to minimize common adverse effects, particularly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation

Thatd be us getting ahead of our skis, he says

More serious but less common adverse effects include pancreatitis, gallbladder problems, and increased heart rate

Compounded versions are typically more cost-accessible than commercially available alternatives